The fungal cell wall is vital for growth, development, and interaction of cells with their environment. The response to cell wall damage is well understood from studies in the budding yeast Saccharomyces cerevisiae, where numerous cell wall integrity (CWI) genes are activated by transcription factor ScRlm1. Prior evidence suggests the hypothesis that both response and regulation may be conserved in the major fungal pathogen Candida albicans. We have tested this hypothesis by using a new C. albicans genetic resource: we have screened mutants defective in putative transcription factor genes for sensitivity to the cell wall biosynthesis inhibitor caspofungin. We find that the zinc finger protein CaCas5, which lacks a unique ortholog in S. cerevisiae, governs expression of many CWI genes. CaRlm1 has a modest role in this response. The transcriptional coactivator CaAda2 is also required for expression of many CaCas5-dependent genes, as expected if CaCas5 recruits CaAda2 to activate target gene transcription. Many caspofungin-induced C. albicans genes specify endoplasmic reticulum and secretion functions. Such genes are not induced in S. cerevisiae, but promote its growth in caspofungin. We have used a new resource to identify a key C. albicans transcriptional regulator of CWI genes and antifungal sensitivity. Our gene expression findings indicate that both divergent and conserved response genes may have significant functional roles. Our strategy may be broadly useful for identification of pathogen-specific regulatory pathways and critical response genes.
For microbial pathogens, the cell wall is critical for interaction with both host and environment. The major fungal pathogen, Candida albicans, has a cell wall that resembles that of the model yeast Saccharomyces cerevisiae, and much of what is known about C. albicans cell wall biogenesis and repair comes via extrapolation from S. cerevisiae. Here, Bruno and colleagues inquired directly into the mechanisms that C. albicans uses to respond to disruption of cell wall biogenesis by the antifungal drug caspofungin, using a genetic strategy newly developed for C. albicans. They found that the response itself has many similarities to that of S. cerevisiae, but the regulatory circuitry is distinct: the major C. albicans regulatory gene has no clear counterpart among S. cerevisiae genes. Their findings provide a new example of a unique C. albicans regulatory function and one that may prove useful in identifying new drugs and in understanding possible resistance mechanisms.
Citation: Bruno VM, Kalachikov S, Subaran R, Nobile CJ, Kyratsous C, et al. (2006) Control of the C. albicans Cell Wall Damage Response by Transcriptional Regulator Cas5. PLoS Pathog 2(3): e21. doi:10.1371/journal.ppat.0020021
Editor: Brendan Cormack, Johns Hopkins University, United States of America
Received: September 2, 2005; Accepted: January 31, 2006; Published: March 17, 2006
Copyright: © 2006 Bruno et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by National Institutes of Health grants R01AI050931, R21AI055823, and T32AI07161.
Competing interests: The authors have received funds from Merck, the manufacturer of caspofungin.
Abbreviations: CWI, cell wall integrity; MAPK, mitogen-activated protein kinase
The cell wall is critical for the interaction of fungal cells with their environment. It provides a resilient framework that permits survival over a wide range of environmental conditions. It is also the point of contact between fungal cells and surfaces to which they may bind. As the determinant of fungal cell shape, it is modified during morphogenetic programs, including budding, mating, hypha production, sporulation, and host invasion by pathogens; genes specifying cell wall proteins and biogenesis enzymes are major targets of developmental regulatory pathways. As a distinguishing fungal structure, the cell wall is the target of natural antifungal metabolites and derivatives of growing therapeutic utility. Thus an understanding of the cell wall and its regulation is relevant to fungal ecology, development, and pathogenesis.
Our interest focuses on the cell wall of Candida albicans, the major invasive fungal pathogen of humans. The C. albicans cell wall is mainly composed of β-1,3-glucan and has significant content of β-1,6-glucan, chitin, and protein as well [1,2]. Molecular studies have begun to dissect C. albicans cell wall functions in adherence, nutrient acquisition, environmental adaptation, and morphogenetic programs. Such analyses have highlighted the role of cell wall functions in virulence [3,4]. The C. albicans cell wall is also of interest as the target of antifungal echinocandin drugs such as caspofungin. Caspofungin inhibits synthesis of β-1,3-glucan in both C. albicans and in the budding yeast Saccharomyces cerevisiae . As a consequence, it provokes a broad transcriptional response in both organisms [6–8]. The response seems geared toward modification and repair of the cell wall, based primarily on the extensive study of gene function and regulatory relationships from S. cerevisiae.
A major determinant of caspofungin sensitivity in S. cerevisiae is the cell wall integrity (CWI) mitogen-activated protein kinase (MAPK) pathway [8–10]. This cascade receives numerous inputs from plasma membrane sensors and signaling molecules. These inputs converge upon G-protein ScRho1, which activates protein kinase ScPkc1. (We use the prefixes “Sc” and “Ca” to indicate S. cerevisiae and C. albicans gene products, respectively.) ScPkc1 in turn activates a MAPK cascade with both transcriptional and nontranscriptional outputs. The transcriptional output is mediated by two transcription factors, ScRlm1 and ScSwi4/6. ScRlm1 is a key activator of many cell wall protein genes and is required for resistance to numerous cell wall perturbing treatments and for activation of most known CWI pathway-responsive genes [11,12]. ScSwi4/6 is known primarily as an activator of G1 phase cell cycle-regulated genes, but it has been implicated in the CWI pathway gene expression response though biochemical and functional analyses .
The S. cerevisiae gene expression response to caspofungin has been probed through microarray analysis [6,8]. Agarwal et al.  reported significant up-regulation by caspofungin of ten ScRlm1-dependent genes—half of all known genes activated by ScRlm1 —as well as ScRLM1 itself. Reinoso-Martin et al.  reported up-regulation by caspofungin of four ScRlm1-dependent genes and again detected up-regulation of ScRLM1. These studies agree that ScRlm1-dependent transcription contributes to the overall response to caspofungin, and the fact that several ScRlm1-dependent genes specify cell wall proteins emphasizes the likelihood that this aspect of the response is functionally significant.
The S. cerevisiae model has been extended to C. albicans through both mutant and microarray analyses. Mutant analysis, driven by a candidate-gene approach, indicates that C. albicans CaPkc1 as well as the CWI MAPK homolog, CaMkc1, are required for cell wall damage responses [13–15]. Microarray studies show that caspofungin induces expression of several cell wall protein and cell wall maintenance genes , including two genes whose S. cerevisiae homologs are activated by ScRlm1. Thus there is the expectation that C. albicans responds to caspofungin through gene products homologous to the S. cerevisiae CWI pathway components, following mechanisms elucidated in S. cerevisiae.
In contrast to that expectation, we describe here a new zinc finger protein, CaCas5, which is required for expression of numerous caspofungin-responsive genes. Mutant analysis suggests that CaCas5 has a major functional role in this response and that the unique role of CaRlm1 is more limited. We also find unique features of the C. albicans caspofungin transcriptional response that parallel S. cerevisiae functional analysis more closely than gene expression analysis. Thus divergent aspects of gene expression responses may provide generally useful guides to direct mutant analysis.
Identification of Transcription Factor Mutants Hypersensitive to Cell Wall Perturbation
In order to identify C. albicans regulators of the cell wall damage response, we screened among mutants homozygous for insertions in 83 putative transcription factor genes  for altered growth on medium containing caspofungin. Mutants with insertions in any of five genes were hypersensitive to caspofungin, including CaCAS1, CaFGR15 (CaCAS2), CaADA2 (CaCAS3), CaCAS4, and CaCAS5. (The gene name CAS stands for caspofungin sensitivity.) We did not identify resistant mutants.
We took three steps to verify that these genes influence the sensitivity of C. albicans to caspofungin. First, we tested multiple isolates of each mutant where possible. These results confirmed the findings from the initial screen. Second, we created deletion mutants for each gene. We observed that Cacas1Δ/Δ and Cafgr15Δ/Δ strains showed only marginal hypersensitivity to the drug. We were unable to create a Cacas4Δ/Δ strain, nor were we able to create homozygous Cacas4::Tn7/Cacas4::Tn7 insertion mutants with Tn7 insertions at codons 836, 842, 1163, and 1828. The viable Cacas4::Tn7/Cacas4::Tn7 mutant has an insertion near codon 2570, very close to the 3′ end of the open reading frame (codon 2831). Thus we believe that CaCAS4 is an essential gene, as is its homolog ScTAO3 in some S. cerevisiae strains, and that the viable insertion mutant has a partial defect in CaCAS4 function. However, viable Caada2Δ/Δ and Cacas5Δ/Δ strains were constructed and showed significant hypersensitivity to caspofungin (Figure 1). The third verification step was to complement each hypersensitive deletion mutant by introduction of a wild-type copy of the corresponding gene. Complementation tests verified that Caada2Δ and Cacas5Δ mutations cause caspofungin hypersensitivity (Figure 1A, 1B, 1D, and 1E). Therefore, CaADA2 and CaCAS5 are required for normal growth of C. albicans in the presence of caspofungin, and the roles of CaCAS1, CaCAS2, and CaCAS4 may be minor or complex.
Serial dilutions of an overnight culture were spotted on YPD medium with no addition (A–C), 25 ng/ml caspofungin (D and E), 125 ng/ml caspofungin (F), or 50 μg/ml Congo red (G–I). Growth was visualized after 1–2 d at 30 °C. The wild-type reference strain (DAY185), mutant (Δ/Δ), and complemented (Δ/Δ/+) strains are shown. All strains were prototrophic; detailed genotypes are listed in Table S2.
The transcription factor ScRlm1 plays a major role in the S. cerevisiae CWI pathway . Thus we tested a C. albicans Carlm1Δ/Δ mutant and complemented derivative for sensitivity to caspofungin. We observed slight growth inhibition of the Carlm1Δ/Δ mutant on our typical caspofungin-containing medium (unpublished data) and a more severe growth defect at higher caspofungin concentrations (Figure 1C and 1F). Complementation with a cloned copy of CaRLM1 restored growth that was comparable to the wild-type reference strain (Figure 1C and 1F). Thus CaRLM1 is required for normal growth in the presence of caspofungin.
The mutants above may be hypersensitive only to caspofungin or may have a more global defect in cell wall structure or integrity. To distinguish between these explanations, we tested growth of the mutants on two additional cell wall perturbing compounds, Congo red and sodium dodecyl sulfate [17,18]. All three mutants were hypersensitive to Congo red (Figure 1G, 1H, and 1I), and the Caada2Δ/Δ and Cacas5Δ/Δ mutants were hypersensitive to sodium dodecyl sulfate (unpublished data). We conclude that CaRLM1, CaADA2, and CaCAS5 functions are not specific for interaction with caspofungin, but are required more generally for cell wall structure or integrity.
Transcriptional Response to Caspofungin
CaRLM1, CaADA2, and CaCAS5 specify putative transcription factors. Thus the mutant phenotypes arise as a consequence of altered gene expression. Because the mutant phenotypes are apparent in the presence of caspofungin, we focused on caspofungin-responsive gene expression.
Pilot microarray studies identified several caspofungin-induced genes, for which we then optimized induction conditions. We examined expression of six genes after an hour of drug treatment and found that 25 ng/ml caspofungin led to partial induction, whereas 125 and 625 ng/ml led to similar levels of induction (Figure 2). This analysis indicated that a 1 h incubation in 125 ng/ml caspofungin would be suitable to elicit some gene expression responses. As this concentration inhibits growth of all three mutants, it seemed reasonable for comparison of wild-type and mutant strains as well.
Wild-type reference strain DAY185 was grown in YPD medium at 30 °C to midexponential phase, and aliquots of the culture received caspofungin at the indicated final concentration. After 1 h of further incubation, RNA was prepared for Northern blot analysis and probed for the indicated transcripts. CaTEF1 was used as a loading control.
In order to identify caspofungin-responsive genes on a large scale, we conducted microarray comparisons of a wild-type reference strain (DAY185) with or without caspofungin treatment for 1 h. Based upon statistical confidence (p < 0.05) and an expression change of at least 2-fold, we identified 216 caspofungin-responsive genes, including 170 up-regulated genes and 46 down-regulated genes (Dataset S1). Fifty-four of these caspofungin-responsive genes were also analyzed by Liu et al.  in a study employing different treatment conditions, a different microarray platform, and the related wild-type strain SC5314. Our assessments of the direction of expression changes correlate with the Liu study for 34 genes, including 23 up-regulated genes and 11 down-regulated genes (Figure 3). We refer to these 34 genes as the core set of caspofungin-responsive genes, indicating that their responses are sufficiently resilient to be detected under diverse conditions.
The expression profiles of 34 caspofungin-responsive genes that (i) exhibited a 2-fold change (p < 0.05) in response to caspofungin treatment in our experiments (Dataset S1) and (ii) exhibited a corresponding increase or decrease in response to caspofungin in the report by Liu et al. . “Gene symbol” refers to entries in CGD. The columns “wt−/wt+,” “ada2/wt+,” “cas5/wt+,” and “rlm1/wt+” summarize the response of each gene in microarray comparisons of the untreated wild-type strain, the treated Caada2Δ/Δ strain, the treated Cacas5Δ/Δ strain, and the treated Carlm1Δ/Δ strain, each compared to the treated wild-type strain, respectively. Green color indicates a higher level of expression in the treated wild-type strain; red color indicates a lower level of expression in the treated wild-type strain. The degree of color saturation represents the magnitude of the expression ratio, which may be found in Dataset S1. The columns “motif 5” and “motif 3” refer to presence of the nucleotide sequences GTGGYSYKGKKG and WTGWTRWTGWTGWKSYKGW, respectively, within 999 bp of each gene's 5′ region; blue color indicates presence of the sequence. The motifs were identified through MEME analysis of CaCas5-dependent gene 5′ regions. Among noncore gene 5′ regions, motif 5 was also associated with orf19.7350, orf19.6595, orf19.753, and orf19.4771; motif 3 was also associated with orf19.13071, orf19.6595, orf19.753, orf19.7350, orf19.4771, and orf19.711.
Relationship between Caspofungin-Sensitive Mutants and Caspofungin-Responsive Genes
To determine whether the caspofungin-sensitive mutants were defective in regulation of caspofungin-responsive genes, we conducted microarray comparisons of each mutant and reference strain DAY185, both treated with caspofungin for 1 h (Figure 3; Dataset S1). Each mutant expressed several caspofungin-responsive genes at levels comparable to the reference strain (black rectangles in lanes of Figure 3), so that no mutant is completely defective in this gene expression response. This observation may indicate that the response to caspofungin integrates activities of several transcriptional regulatory pathways.
The Carlm1Δ/Δ mutant had a fairly mild gene expression alteration. It failed to fully express only four up-regulated genes (one of which was CaRLM1 itself) and overexpressed two additional up-regulated genes. Our dataset includes three genes up-regulated by caspofungin whose S. cerevisiae homologs are activated by ScRlm1: CaCRH11, CaECM331, and CaDFG5. CaECM331 and CaDFG5 were expressed at similar levels in the wild-type reference strain and the Carlm1Δ/Δ mutant; CaCRH11 expression was reduced slightly in the mutant (Figure 3; Dataset S1). These observations suggest that a different transcription factor may have assumed the key functional role in CWI signaling in C. albicans.
The Caada2Δ/Δ mutant had the most severe gene expression alteration. It failed to fully express 59 up-regulated genes; it overexpressed nine up-regulated genes; it failed to fully repress five down-regulated genes; and it hyperrepressed five down-regulated genes. The mutant also had altered expression of 180 genes that were not significantly responsive to caspofungin (Dataset S1). CaAda2 homologs in other eukaryotes have broad roles in gene expression as transcriptional coactivators . The fact that the Caada2Δ/Δ mutant has such a pleiotropic effect on gene expression fits well with the idea that C. albicans CaAda2 is a coactivator, functioning in diverse regulatory pathways.
The Cacas5Δ/Δ mutant also had severe gene expression defect. It failed to fully express 37 up-regulated genes and failed to repress nine down-regulated genes (Figure 3; Dataset S1). Noteworthy was its defect in expression of CaCRH11 and CaECM331, two caspofungin-induced homologs of ScRlm1-dependent genes, and seven other core caspofungin-inducible genes (Figure 3). Northern analysis confirmed its expression defect for core genes CaCRH11, CaECM331, and CaPGA13, as well as CaPGA23 and CaHAC1 (Figure 4). Because the mutant had altered expression of only 15 genes that were not significantly responsive to caspofungin (Dataset S1), CaCas5 function seems to be substantially specific for cell wall damage-responsive gene expression.
Reference strain DAY185 and prototrophic Cacas5Δ/Δ mutant VIC1186 were grown and treated with 125 ng/ml caspofungin as described for Figure 2. RNA was prepared for Northern blot analysis and probed for the indicated transcripts. The rRNA bands visualized with ethidium bromide staining were used as a loading control.
Caspofungin-Responsive Gene Function in C. albicans
Our current understanding of fungal cell wall damage responses comes largely from studies in S. cerevisiae, an essential point of comparison. We found 125 C. albicans caspofungin-responsive genes whose S. cerevisiae homologs were described in two studies of that organism's response to caspofungin [6,8]. Only five homologs of genes up-regulated in our study were up-regulated in both S. cerevisiae studies: CaECM331/ScPST1, CaCRH11/ScCRH1, CaDFG5/ScDFG5, CaRLM1/ScRLM1, and CaGYP7/ScGYP7. The first three genes depend upon ScRlm1 for their expression in S. cerevisiae and encode inferred or proven GPI-linked cell surface proteins that have been implicated in cell wall biogenesis or repair [20–23]. CaRLM1/ScRLM1 governs cell wall functions in both organisms, as discussed below. Up-regulation of cell wall functions is also reflected in the core C. albicans responses (p = 7.95 × 10−11 for 9/25 S. cerevisiae homologs; http://db.yeastgenome.org/cgi-bin/GO/goTermFinder) and in our overall dataset. Thus both conserved and overall C. albicans caspofungin-induced genes have a close functional relationship to cell wall biogenesis or repair, as noted previously for S. cerevisiae [6,8].
The conserved up-regulation of CaGYP7/ScGYP7 may reflect the need for surface export functions during cell wall repair. ScGYP7 specifies the GTPase-activating protein for G-Protein ScYpt1, which promotes Golgi-to-vacuole transport . Up-regulation of CaGyp7 may thus inhibit transport to the vacuole, perhaps favoring transport of material from the Golgi to the cell surface. Two prior findings with S. cerevisiae suggest that cell surface transport is limiting for cell wall repair: overexpression of Golgi-to-cell surface transport stimulator ScSBE2 confers resistance to caspofungin , and defects in secretion cause hypersensitivity to caspofungin . Among our overall set of caspofungin-induced C. albicans genes, there is a clear representation of cytoplasmic vesicle or organelle lumen functions (p = 2.47 × 10−5 for 4/108 S. cerevisiae homologs or 0.01588 for 6/144 C. albicans genes; http://www.candidagenome.org/cgi-bin/GO/goTermFinder). Noteworthy also is up-regulation of CaHAC1 (Figure 4); its homolog ScHAC1 specifies the transcriptional activator of the unfolded protein response, an endoplasmic reticulum stress-response pathway [26,27]. However, secretion functions are not represented among caspofungin-induced S. cerevisiae genes [6,8]; instead, they are down-regulated in one set of experiments (p = 0.00791 for 3/133 genes ). The symmetry between the genes induced in C. albicans and those required in S. cerevisiae in the presence of caspofungin illustrates that divergent gene expression responses may highlight conserved functional relationships.
There is only one homolog pair whose down-regulation after caspofungin treatment is conserved: CaHAS1/ScHAS1. ScHas1 is a putative helicase required for rRNA processing and ribosome biogenesis, and its expression is down-regulated in response to numerous environmental stresses . Down-regulation of ribosome biogenesis functions is also reflected in our overall dataset (p = 0.00576 for 6/42 C. albicans genes). This response to caspofungin may reflect a coupling between cell wall biogenesis and overall cell growth.
Role of CaRlm1 in CWI
Our analysis of CaRLM1 here was motivated by a candidate-gene approach, based on the central role of ScRlm1 in the S. cerevisiae CWI pathway. This role is emphasized by the fact that CaRLM1 expression is induced by caspofungin in both C. albicans and S. cerevisiae. The drug hypersensitivity of the C. albicans Carlm1Δ/Δ mutant reported here implicates CaRlm1 in the C. albicans cell wall damage response, thus arguing that its biological function is conserved.
Although conservation of CaRlm1 biological function is expected, the fact that we found so few CaRlm1-dependent genes seems surprising. The major caspofungin-inducible Rlm1-dependent gene we detected was CaPGA13 (orf19.6420), a gene in the core set that specifies a predicted GPI-linked cell wall protein without close homologs. It is possible that CaPga13 is required for C. albicans cell wall repair. We also detected partial CaRlm1-dependence of CaCRH11, a result that has been confirmed by Northern analysis (unpublished results). Thus there may be only two cell wall-related targets of CaRlm1. A second possibility is that CaRlm1-dependent genes are induced only at earlier or later time points than we have examined here.
Role of CaAda2 in CWI
CaAda2 homologs are subunits of transcriptional coactivator complexes that are recruited by site-specific DNA binding proteins such as ScGcn4 and ScGal4 to activate transcription . Our microarray results are consistent with the hypothesis that C. albicans CaAda2 functions in conjunction with many different regulators, because CaAda2-responsive genes are more numerous than CaRlm1- or CaCas5-responsive genes and extend well beyond the set of caspofungin-responsive genes.
There is a substantial effect of the Caada2Δ/Δ mutation on caspofungin-responsive genes. These results may be explained by either indirect or direct roles of CaAda2 in this response. One hypothetical indirect role is that CaAda2 may be required for expression of genes that are in turn required for caspofungin-induced gene expression. The fact that CaAda2-responsive genes are so numerous makes this explanation difficult to test. A hypothetical direct role of CaAda2 is that it may be recruited to caspofungin-induced gene regulatory regions through interaction with a site-specific DNA binding protein, where it participates directly in their transcriptional activation. Given that 25 of the 30 most highly CaCas5-dependent genes are also CaAda2-dependent, this explanation predicts that CaCas5 may activate transcription through recruitment of CaAda2. One prediction of this hypothesis is that a double Caada2Δ/Δ Cacas5Δ/Δ mutant should have the same phenotype as one or the other single mutant. We have been unable to construct the double mutant with methods that are routinely successful in this lab, and it is possible that the two mutations are synthetically lethal. Thus a critical test of this hypothesis will require other strategies.
Role of CaCas5 in CWI
CaCas5 has a major role in the C. albicans cell wall damage response. Among the mutants we have screened, it is the most sensitive to both caspofungin and Congo red. It is required for full expression of 15 of the 30 genes most highly induced by caspofungin, and nine genes in the C. albicans core set. Noteworthy among these are CaECM331 and CaCRH11, whose S. cerevisiae homologs are ScRlm1-dependent. In general, the major class of caspofungin–induced CaCas5-dependent genes include cell wall functions (p = 1.75 × 10−5 for S. cerevisiae homologs; 5/22 genes). Thus C. albicans CaCas5 may be the functional equivalent of S. cerevisiae ScRlm1.
The closest S. cerevisiae homolog of CaCas5 is ScMig2, a repressor of glucose-repressible genes. However, the C. albicans orf19.5326 product, rather than CaCas5, appears to be the ScMig2 ortholog. There are now several examples of novel transcriptional regulators in C. albicans with key biological functions, as well as conserved transcriptional regulators with divergent functions in C. albicans and S. cerevisiae [16,30–35]. These two considerations—functionally divergent homologs and unique key regulators—underscore the importance of analyzing C. albicans gene function de novo, rather than relying solely upon inferences from S. cerevisiae.
Similarity of CaCas5 and ScMig2 is confined to their two C-terminal zinc fingers, but the degree of similarity (51% identity) does not provide confidence that Cas5 binds to the Mig2 consensus binding site, ATAAAAATGCGGGGAA . We have used MEME analysis (http://meme.sdsc.edu/meme/website/intro.html ) of CaCas5-responsive gene 5′ regions to look for motifs that may represent a CaCas5-responsive site or CaCas5 binding site. We focused on 999 base pairs of 5′ sequence from the 13 top CaCas5-dependent genes. One motif, WTGWTRWTGWTGWKSYKGW (motif 3), was found in ten of the 13 promoter regions, including four core genes (Figure 3; Protocol S1; Figure S1). The site seems credible because its length is similar to that of the ScMig2 binding site (19 and 17 bp, respectively) and because the best matches are found among the more highly CaCas5-dependent genes. A second shorter motif, GTGGYSYKGKKG (motif 5), was found among nine promoter regions, including five core genes (Figure 3). Our working hypothesis is that one of these sequences may be a CaCas5 binding site.
Our findings provide some insight into the relationships among CaCas5, its target genes, and the role of CaCas5 in the cell wall damage response. They also raise the question of whether and how CaCas5 responds to cell wall damage. The simplest possibility is that CaCas5 is a target of the protein kinase C–MAPK pathway. The C. albicans MAPK of this pathway, CaMkc1, clearly functions in cell wall damage responses [13,14]. Our preliminary results indicate that CaMkc1, the MAPKKK homolog CaBck1, and the MAPKK homolog CaMkk2 are required for growth in the presence of caspofungin, in keeping with this model. A second possibility is that CaCas5 is the target of a different pathway that responds to cell wall damage. There are several good candidates—the calcineurin or high-osmolarity pathways, for example—based on studies in S. cerevisiae . It is also possible that CaCas5 functions in a novel C. albicans pathway. We anticipate that these many possibilities may be addressed by screening C. albicans mutants defective in other kinds of gene products, such as protein kinases or membrane proteins, for defects that might be expected from altered CaCas5 activity.
Materials and Methods
Media and chemicals.
C. albicans strains were routinely passaged in YPD plus uridine (2% dextrose, 2% Bacto Peptone, 1% yeast extract, and 80 mgl/l uridine) at 30 °C. Following transformation, selection was accomplished on synthetic medium (2% dextrose, 6.7% yeast nitrogen base (YNB) plus ammonium sulfate, and the necessary auxotrophic supplements). Caspofungin was a generous gift from Merck.
Yeast strains and DNA manipulations.
All strains used in this study were derived from strain BWP17 (genotype: ura3Δ::λimm434/ura3Δ::λimm434 his1::hisG/his1::hisG arg4::hisg/arg4::hisG ) through standard transformation methods . Details of these manipulations and complete genotypes are given in Protocol S1, Table S1, and Table S2. The transcription factor mutant collection has been described .
Caspofungin susceptibility tests.
Single colonies were inoculated into 3 ml of YPD and grown overnight at 30 °C. These overnight cultures were then diluted in YPD to an OD600 of 3.0, which was used as a starting point for 5-fold serial dilutions in YPD. 3 μl of each serial dilution, beginning with the OD600 = 3.0 dilution, was spotted onto the appropriate plates, allowed to dry, and incubated at 30 °C. The plates were photographed after 1 or 2 d of growth.
Gene expression measurements and microarray data analysis.
Single colonies were inoculated into 3 ml of YPD and grown overnight at 30 °C. Each overnight culture was used to inoculate 200 ml of YPD to an OD600 of 0.1, which was then incubated at 30 °C with shaking for 2–3 doublings. At this point the cultures were divided into two 100-ml cultures. To one of the cultures, caspofungin (diluted in dH20) was added to a final concentration of 125 ng/ml. To the other culture an equal volume of dH20 was added. The cultures were then incubated with shaking at 30 °C for 1 h, at which point they were harvested by vacuum filtration and stored at −80 °C. RNA isolation, microarray analysis, and Northern analysis were performed as previously described . Microarray slides were scanned using ScanArray Express microarray scanner (PerkinElmer, Wellesley, California, United States), and the signal intensities were extracted with GenePix Pro 4.1 software (Axon Instruments, Union City, California, United States). Raw signal intensities were corrected for dye labeling effects within and between all slides using the normalize.loess R-function  implemented in an affy microarray analysis package . The resulting data were imported into the Spotfire DecisionSite for Functional Genomics software suite (Spotfire, Somerville, Massachusetts, United States) and filtered according to the GenePix quality scores above 0 and signal-to-noise ratio above 2. The p-values for differentially expressed genes between the compared strains were subsequently calculated and further adjusted for type I error with Bonferroni's transformation using BioConductor multtest R-package  (see http://cran.r-project.org/doc/packages/multtest.pdf). The results of this analysis with adjusted p-values below 0.05 and absolute fold changes above 2 are listed in Dataset S1. All told, we compared three hybridizations with untreated wild-type cell samples and 12 hybridizations with drug-treated wild-type cell samples to identify caspofungin-responsive genes. We compared three hybridizations of drug-treated mutant cells to drug-treated wild-type cells to identify dependent genes for each mutant. RNA for each sample came from an independent culture.
Dataset S1. Microarray Analysis of Caspofungin-Responsive Gene Expression
These data compare the wild-type plus and minus treatment, the wild-type to each mutant, and our data to related published S. cerevisiae and C. albicans data.
(6.1 MB XLS)
Figure S1. MEME Analysis Results
This figure shows the results of 5′ region MEME analysis.
(315 KB DOC)
Protocol S1. Supplementary Methods
(58 KB DOC)
Table S1. Oligonucleotide Sequences
(48 KB DOC)
Table S2. Complete Genotypes of C. albicans Strains
(37 KB DOC)
Data for the following genes and mutant alleles (with systematic names in parentheses) are deposited in the Candida Genome Database (http://www.candidagenome.org): CaCAS1 (orf19.1135), CaFGR15 or CaCAS2 (orf19.2054), CaADA2 or CaCAS3 (orf19.2331), CaCAS4 (orf19.9261), CaCAS5 (orf19.4670), CaRLM1 (orf19.4662), and CaPGA13 (orf19.6420).
We are grateful for the availability of the C. albicans genome sequence provided by the Stanford DNA Sequencing and Technology Center, as well as CandidaDB and the Candida Genome Database. We thank members of our laboratory for advice and discussions, Omar Antar for his help with initial aspects of this work, and Joe Heitman for providing glass slide arrays. We are especially grateful to Merck for the gift of caspofungin and to Cameron Douglas and Jennifer Nielsen Kahn for their interest and encouragement.
VMB, RS, and APM conceived and designed the experiments. VMB, RS, CJN, and CK performed the experiments. VMB, SK, CJN, and APM analyzed the data. VMB and CJN contributed reagents/materials/analysis tools. VMB, SK, RJ, CJN, and APM wrote the paper.
- 1. De Groot PW, Ram AF, Klis FM (2005) Features and functions of covalently linked proteins in fungal cell walls. Fungal Genet Biol 42: 657–675.
- 2. Masuoka J (2004) Surface glycans of Candida albicans and other pathogenic fungi: Physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 17: 281–310.
- 3. Navarro-Garcia F, Sanchez M, Nombela C, Pla J (2001) Virulence genes in the pathogenic yeast Candida albicans. FEMS Microbiol Rev 25: 245–268.
- 4. Sundstrom P (2002) Adhesion in Candida spp. Cell Microbiol 4: 461–469.
- 5. Letscher-Bru V, Herbrecht R (2003) Caspofungin: The first representative of a new antifungal class. J Antimicrob Chemother 51: 513–521.
- 6. Agarwal AK, Rogers PD, Baerson SR, Jacob MR, Barker KS, et al. (2003) Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem 278: 34998–35015.
- 7. Liu TT, Lee RE, Barker KS, Lee RE, Wei L, et al. (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49: 2226–2236.
- 8. Reinoso-Martin C, Schuller C, Schuetzer-Muehlbauer M, Kuchler K (2003) The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot Cell 2: 1200–1210.
- 9. Levin DE (2005) Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 69: 262–291.
- 10. Lesage G, Sdicu AM, Menard P, Shapiro J, Hussein S, et al. (2004) Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin. Genetics 167: 35–49.
- 11. Jung US, Levin DE (1999) Genome-wide analysis of gene expression regulated by the yeast cell wall integrity signalling pathway. Mol Microbiol 34: 1049–1057.
- 12. Jung US, Sobering AK, Romeo MJ, Levin DE (2002) Regulation of the yeast Rlm1 transcription factor by the Mpk1 cell wall integrity MAP kinase. Mol Microbiol 46: 781–789.
- 13. Navarro-Garcia F, Alonso-Monge R, Rico H, Pla J, Sentandreu R, et al. (1998) A role for the MAP kinase gene MKC1 in cell wall construction and morphological transitions in Candida albicans. Microbiology 144(Pt 2): 411–424.
- 14. Navarro-Garcia F, Eisman B, Roman E, Nombela C, Pla J (2001) Signal transduction pathways and cell-wall construction in Candida albicans. Med Mycol 39(Suppl 1): 87–100.
- 15. Paravicini G, Mendoza A, Antonsson B, Cooper M, Losberger C, et al. (1996) The Candida albicans PKC1 gene encodes a protein kinase C homolog necessary for cellular integrity but not dimorphism. Yeast 12: 741–756.
- 16. Nobile CJ, Mitchell AP (2005) Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15: 1150–1155.
- 17. Page N, Gerard-Vincent M, Menard P, Beaulieu M, Azuma M, et al. (2003) A Saccharomyces cerevisiae genome-wide mutant screen for altered sensitivity to K1 killer toxin. Genetics 163: 875–894.
- 18. Roncero C, Duran A (1985) Effect of Calcofluor white and Congo red on fungal cell wall morphogenesis: In vivo activation of chitin polymerization. J Bacteriol 163: 1180–1185.
- 19. Timmers HT, Tora L (2005) SAGA unveiled. Trends Biochem Sci 30: 7–10.
- 20. Pardo M, Monteoliva L, Vazquez P, Martinez R, Molero G, et al. (2004) PST1 and ECM33 encode two yeast cell surface GPI proteins important for cell wall integrity. Microbiology 150: 4157–4170.
- 21. Spreghini E, Davis DA, Subaran R, Kim M, Mitchell AP (2003) Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation. Eukaryot Cell 2: 746–755.
- 22. Kitagaki H, Wu H, Shimoi H, Ito K (2002) Two homologous genes, DCW1 (YKL046c) and DFG5, are essential for cell growth and encode glycosylphosphatidylinositol (GPI)-anchored membrane proteins required for cell wall biogenesis in Saccharomyces cerevisiae. Mol Microbiol 46: 1011–1022.
- 23. Terashima H, Yabuki N, Arisawa M, Hamada K, Kitada K (2000) Up-regulation of genes encoding glycosylphosphatidylinositol (GPI)-attached proteins in response to cell wall damage caused by disruption of FKS1 in Saccharomyces cerevisiae. Mol Gen Genet 264: 64–74.
- 24. Vollmer P, Will E, Scheglmann D, Strom M, Gallwitz D (1999) Primary structure and biochemical characterization of yeast GTPase-activating proteins with substrate preference for the transport GTPase Ypt7p. Eur J Biochem 260: 284–290.
- 25. Osherov N, May GS, Albert ND, Kontoyiannis DP (2002) Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob Agents Chemother 46: 2462–2469.
- 26. Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls. Genes Dev 13: 1211–1233.
- 27. Shamu CE (1997) Splicing together the unfolded-protein response. Curr Biol 7: R67–R70.
- 28. Gasch AP, Spellman PT, Kao CM, Carmel-Harel O, Eisen MB, et al. (2000) Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 11: 4241–4257.
- 29. Belotserkovskaya R, Berger SL (1999) Interplay between chromatin modifying and remodeling complexes in transcriptional regulation. Crit Rev Eukaryot Gene Expr 9: 221–230.
- 30. Nicholls S, Straffon M, Enjalbert B, Nantel A, Macaskill S, et al. (2004) Msn2- and Msn4-like transcription factors play no obvious roles in the stress responses of the fungal pathogen Candida albicans. Eukaryot Cell 3: 1111–1123.
- 31. Chen CG, Yang YL, Shih HI, Su CL, Lo HJ (2004) CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Chemother 48: 4505–4512.
- 32. Inglis DO, Johnson AD (2002) Ash1 protein, an asymmetrically localized transcriptional regulator, controls filamentous growth and virulence of Candida albicans. Mol Cell Biol 22: 8669–8680.
- 33. Bensen ES, Filler SG, Berman J (2002) A forkhead transcription factor is important for true hyphal as well as yeast morphogenesis in Candida albicans. Eukaryot Cell 1: 787–798.
- 34. Khalaf RA, Zitomer RS (2001) The DNA binding protein Rfg1 is a repressor of filamentation in Candida albicans. Genetics 157: 1503–1512.
- 35. Kadosh D, Johnson AD (2001) Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol Cell Biol 21: 2496–2505.
- 36. Lutfiyya LL, Iyer VR, DeRisi J, DeVit MJ, Brown PO, et al. (1998) Characterization of three related glucose repressors and genes they regulate in Saccharomyces cerevisiae. Genetics 150: 1377–1391.
- 37. Bailey TL, Elkan C (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2: 28–36.
- 38. Wilson RB, Davis D, Mitchell AP (1999) Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol 181: 1868–1874.
- 39. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185–193.
- 40. Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) Affy—Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307–315.
- 41. van der Laan MJ, Dudoit S, Pollard KS (2004) Augmentation procedures for control of the generalized family-wise error rate and tail probabilities for the proportion of false positives. Stat App Genet Mol Biol. 3. Article 15.